Filtrer efter Last updated date SelectEfterFørFrom - To Dato Slutdato Denne uge Denne måned Seneste uge Seneste måned Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Efterlad dette felt tomt Filter Resultater (3800) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Efterlad dette felt tomt Supply shortage of Cerezyme – updated treatment recommendations required 14 august 2009Press release EudraGMP 2.0 gives public access to information about good manufacturing practice (GMP) 4 august 2009Press releaseCompliance and inspections European Medicines Agency and U.S. Food and Drug Administration (FDA) launch Good Clinical Practice Initiative 3 august 2009Press releaseMedicines Meeting highlights from the Paediatric Committee: 22 - 24 July 2009 31 juli 2009Press releaseHumanPaediatrics European Medicines Agency update on safety of insulin glargine - Update 29 juli 2009Press releaseMedicines GlaxoSmithKline withdraws its marketing authorisation application for Bosatria (mepolizumab) 29 juli 2009Press release European Medicines Agency review of pandemic vaccines underway 24 juli 2009Press releaseMedicines Meeting highlights from the Committee for Medicinal Products for Human Use,20-23 July 2009 24 juli 2009Press releaseHuman Gendux Molecular Limited withdraws its marketing authorisation application for Contusugene ladenovec Gendux (contusugene ladenovec) 23 juli 2009Press release Committee for medicinal products for veterinary use: Meeting of 14-16 July 2009 17 juli 2009Press releaseVeterinary 1 … 296 297 298 299 300 Page 300 of 380 301 302 303 304 … 380
EudraGMP 2.0 gives public access to information about good manufacturing practice (GMP) 4 august 2009Press releaseCompliance and inspections
European Medicines Agency and U.S. Food and Drug Administration (FDA) launch Good Clinical Practice Initiative 3 august 2009Press releaseMedicines
Meeting highlights from the Paediatric Committee: 22 - 24 July 2009 31 juli 2009Press releaseHumanPaediatrics
European Medicines Agency update on safety of insulin glargine - Update 29 juli 2009Press releaseMedicines
GlaxoSmithKline withdraws its marketing authorisation application for Bosatria (mepolizumab) 29 juli 2009Press release
Meeting highlights from the Committee for Medicinal Products for Human Use,20-23 July 2009 24 juli 2009Press releaseHuman
Gendux Molecular Limited withdraws its marketing authorisation application for Contusugene ladenovec Gendux (contusugene ladenovec) 23 juli 2009Press release
Committee for medicinal products for veterinary use: Meeting of 14-16 July 2009 17 juli 2009Press releaseVeterinary